Clinical trial
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic…
NCT00043316 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00043316 |
|---|---|
| Title | Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis |
| Official title | A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | interferon gamma-1b |
| Enrollment | 66 |
| Start date | Feb 1, 2001 |
| Completion | Oct 1, 2002 |
| First posted | Aug 9, 2002 |
| Last update posted | Nov 1, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: